• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白激酶C通过提高ATP水解速率来调节拓扑异构酶II的催化活性:磷酸化调节的共同机制的证据。

Protein kinase C modulates the catalytic activity of topoisomerase II by enhancing the rate of ATP hydrolysis: evidence for a common mechanism of regulation by phosphorylation.

作者信息

Corbett A H, Fernald A W, Osheroff N

机构信息

Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146.

出版信息

Biochemistry. 1993 Mar 2;32(8):2090-7. doi: 10.1021/bi00059a029.

DOI:10.1021/bi00059a029
PMID:8383533
Abstract

The catalytic activity of topoisomerase II is stimulated approximately 2-3-fold following phosphorylation by either casein kinase II or protein kinase C. A previous study [Corbett, A. H., DeVore, R. F., & Osheroff, N. (1992) J. Biol. Chem. 267, 20513-20518] demonstrated that casein kinase II regulates the activity of topoisomerase II by specifically enhancing the ability of the enzyme to hydrolyze its ATP cofactor. To determine whether other protein kinases use a similar mechanism to activate the enzyme, the effects of protein kinase C mediated phosphorylation on the individual steps of the topoisomerase II catalytic cycle were assessed. Modification stimulated rates of enzyme-mediated ATP hydrolysis approximately 2.7-fold, but had no effect on any reaction that preceded this step, including enzyme.DNA binding, pre- or poststrand passage DNA cleavage/religation, or the double-stranded DNA strand passage event. Furthermore, the activation of ATP hydrolysis was reversed following treatment of phosphorylated topoisomerase II with alkaline phosphatase. As determined by partial proteolytic mapping, the site(s) of protein kinase C modification was (were) localized to the 350 amino acid C-terminal regulatory domain of topoisomerase II within approximately 50 amino acids of the site(s) phosphorylated by casein kinase II. Finally, while protein kinase C and casein kinase II were able to modify the enzyme simultaneously, rates of ATP hydrolysis for doubly-modified topoisomerase II were comparable to those observed for the enzyme following phosphorylation by either individual kinase.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

酪蛋白激酶II或蛋白激酶C磷酸化后,拓扑异构酶II的催化活性大约可被刺激2至3倍。先前的一项研究[科比特,A. H.,德沃尔,R. F.,& 奥舍罗夫,N.(1992年)《生物化学杂志》267卷,20513 - 20518页]表明,酪蛋白激酶II通过特异性增强该酶水解其ATP辅因子的能力来调节拓扑异构酶II的活性。为了确定其他蛋白激酶是否使用类似机制激活该酶,评估了蛋白激酶C介导的磷酸化对拓扑异构酶II催化循环各个步骤的影响。修饰使酶介导的ATP水解速率提高了约2.7倍,但对该步骤之前的任何反应均无影响,包括酶与DNA的结合、链通过前或后的DNA切割/连接,或双链DNA链通过事件。此外,用碱性磷酸酶处理磷酸化的拓扑异构酶II后,ATP水解的激活作用被逆转。通过部分蛋白水解图谱分析确定,蛋白激酶C修饰位点位于拓扑异构酶II的350个氨基酸的C末端调节结构域内,在酪蛋白激酶II磷酸化位点的大约50个氨基酸范围内。最后,虽然蛋白激酶C和酪蛋白激酶II能够同时修饰该酶,但双重修饰的拓扑异构酶II的ATP水解速率与单独一种激酶磷酸化后观察到的速率相当。(摘要截选至250字)

相似文献

1
Protein kinase C modulates the catalytic activity of topoisomerase II by enhancing the rate of ATP hydrolysis: evidence for a common mechanism of regulation by phosphorylation.蛋白激酶C通过提高ATP水解速率来调节拓扑异构酶II的催化活性:磷酸化调节的共同机制的证据。
Biochemistry. 1993 Mar 2;32(8):2090-7. doi: 10.1021/bi00059a029.
2
Effect of casein kinase II-mediated phosphorylation on the catalytic cycle of topoisomerase II. Regulation of enzyme activity by enhancement of ATP hydrolysis.
J Biol Chem. 1992 Oct 5;267(28):20513-8.
3
Phosphorylation of DNA topoisomerase II in vivo and in total homogenates of Drosophila Kc cells. The role of casein kinase II.果蝇Kc细胞体内及全细胞匀浆中DNA拓扑异构酶II的磷酸化作用。酪蛋白激酶II的作用。
J Biol Chem. 1988 Sep 5;263(25):12653-60.
4
Phosphorylation of topoisomerase II by casein kinase II and protein kinase C: effects on enzyme-mediated DNA cleavage/religation and sensitivity to the antineoplastic drugs etoposide and 4'-(9-acridinylamino)methane-sulfon-m-anisidide.酪蛋白激酶II和蛋白激酶C对拓扑异构酶II的磷酸化作用:对酶介导的DNA切割/连接的影响以及对抗肿瘤药物依托泊苷和4'-(9-吖啶基氨基)甲磺基间茴香胺的敏感性。
Cancer Res. 1992 Apr 15;52(8):2156-61.
5
Effects of topoisomerase II-targeted drugs on enzyme-mediated DNA cleavage and ATP hydrolysis: evidence for distinct drug interaction domains on topoisomerase II.拓扑异构酶II靶向药物对酶介导的DNA切割和ATP水解的影响:拓扑异构酶II上不同药物相互作用结构域的证据。
Biochemistry. 1993 Apr 13;32(14):3638-43. doi: 10.1021/bi00065a016.
6
Effects of antineoplastic drugs on the post-strand-passage DNA cleavage/religation equilibrium of topoisomerase II.抗肿瘤药物对拓扑异构酶II链通过后DNA切割/连接平衡的影响。
Biochemistry. 1991 Feb 19;30(7):1807-13. doi: 10.1021/bi00221a012.
7
Phosphorylation of DNA topoisomerase II by casein kinase II: modulation of eukaryotic topoisomerase II activity in vitro.
Proc Natl Acad Sci U S A. 1985 May;82(10):3164-8. doi: 10.1073/pnas.82.10.3164.
8
The p53 tumor suppressor stimulates the catalytic activity of human topoisomerase IIalpha by enhancing the rate of ATP hydrolysis.p53肿瘤抑制蛋白通过提高ATP水解速率来刺激人拓扑异构酶IIα的催化活性。
J Biol Chem. 2000 Jun 16;275(24):18503-10. doi: 10.1074/jbc.M002081200.
9
Purification and characterization of type II DNA topoisomerase from mouse FM3A cells: phosphorylation of topoisomerase II and modification of its activity.小鼠FM3A细胞II型DNA拓扑异构酶的纯化与特性分析:拓扑异构酶II的磷酸化及其活性修饰
Biochemistry. 1990 Jan 16;29(2):583-90. doi: 10.1021/bi00454a036.
10
Hindering the strand passage reaction of human topoisomerase IIalpha without disturbing DNA cleavage, ATP hydrolysis, or the operation of the N-terminal clamp.在不干扰DNA切割、ATP水解或N端夹子运作的情况下,阻碍人类拓扑异构酶IIα的链通过反应。
J Biol Chem. 2004 Jul 2;279(27):28093-9. doi: 10.1074/jbc.M402120200. Epub 2004 Apr 28.

引用本文的文献

1
The interplay between DNA topoisomerase 2α post-translational modifications and drug resistance.DNA拓扑异构酶2α翻译后修饰与耐药性之间的相互作用。
Cancer Drug Resist. 2020 Feb 27;3(2):149-160. doi: 10.20517/cdr.2019.114. eCollection 2020.
2
Cell Cycle-Dependent Control and Roles of DNA Topoisomerase II.细胞周期依赖性控制与 DNA 拓扑异构酶 II 的作用。
Genes (Basel). 2019 Oct 30;10(11):859. doi: 10.3390/genes10110859.
3
A Topology-Centric View on Mitotic Chromosome Architecture.有丝分裂染色体结构的拓扑中心观
Int J Mol Sci. 2017 Dec 18;18(12):2751. doi: 10.3390/ijms18122751.
4
Phase I study of bryostatin 1, a protein kinase C modulator, preceding cisplatin in patients with refractory non-hematologic tumors.蛋白激酶C调节剂苔藓抑素1在难治性非血液系统肿瘤患者中先于顺铂的I期研究。
Cancer Chemother Pharmacol. 2009 Sep;64(4):803-10. doi: 10.1007/s00280-009-0931-y. Epub 2009 Feb 17.
5
Characterisation of the DNA-dependent ATPase activity of human DNA topoisomerase IIbeta: mutation of Ser165 in the ATPase domain reduces the ATPase activity and abolishes the in vivo complementation ability.人DNA拓扑异构酶IIβ的DNA依赖性ATP酶活性的表征:ATP酶结构域中Ser165的突变降低了ATP酶活性并消除了体内互补能力。
Nucleic Acids Res. 2002 Dec 15;30(24):5416-24. doi: 10.1093/nar/gkf677.
6
Extracellular signal-regulated kinase activates topoisomerase IIalpha through a mechanism independent of phosphorylation.细胞外信号调节激酶通过一种独立于磷酸化的机制激活拓扑异构酶IIα。
Mol Cell Biol. 1999 May;19(5):3551-60. doi: 10.1128/MCB.19.5.3551.
7
Altered stability of etoposide-induced topoisomerase II-DNA complexes in resistant human leukaemia K562 cells.依托泊苷诱导的拓扑异构酶II - DNA复合物在耐药人白血病K562细胞中的稳定性改变
Br J Cancer. 1994 Apr;69(4):687-97. doi: 10.1038/bjc.1994.131.
8
Structure and function of type II DNA topoisomerases.II型DNA拓扑异构酶的结构与功能。
Biochem J. 1994 Nov 1;303 ( Pt 3)(Pt 3):681-95. doi: 10.1042/bj3030681.